![](/img/cover-not-exists.png)
PDG12: CLINICAL BENEFITS AND COST-OFFSETS OF COMBINATION THERAPY WITH NATEGLINIDE PLUS METFORMIN VERSUS METFORMIN ALONE IN DIABETES IN THE NETHERLANDS
Boom G van den, MA Koopmanschap, J Caro, J GruegerVolume:
4
Year:
2001
Language:
english
DOI:
10.1016/s1098-3015(11)71749-1
File:
PDF, 67 KB
english, 2001